• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Ruxolitinib in the treatment of two cases of chronic neutrophilic leukemia].

作者信息

Zheng W S, Guan L X, Cheng L C, Hu Y L, Xu Y Y, Yang T, Peng B, Wu Y L, Bo J, Wang Q S, Gao X N

机构信息

Department of Hematology, Hainan Hospital of Chinese PLA General Hospital, Sanya 572000, China.

Department of Hematology, Chinese PLA General Hospital, Beijing 100853, China.

出版信息

Zhonghua Zhong Liu Za Zhi. 2020 Feb 23;42(2):113-114. doi: 10.3760/cma.j.issn.0253-3766.2020.02.005.

DOI:10.3760/cma.j.issn.0253-3766.2020.02.005
PMID:32135644
Abstract
摘要

相似文献

1
[Ruxolitinib in the treatment of two cases of chronic neutrophilic leukemia].
Zhonghua Zhong Liu Za Zhi. 2020 Feb 23;42(2):113-114. doi: 10.3760/cma.j.issn.0253-3766.2020.02.005.
2
Clinical response to ruxolitinib in CSF3R T618-mutated chronic neutrophilic leukemia.鲁索替尼治疗CSF3R T618突变型慢性中性粒细胞白血病的临床反应。
Ann Hematol. 2016 Jun;95(7):1197-200. doi: 10.1007/s00277-016-2664-4. Epub 2016 Apr 11.
3
Effects of ruxolitinib on secondary myelofibrosis following chronic neutrophilic leukemia with the CSF3R T618I mutation.鲁索替尼对伴有CSF3R T618I突变的慢性嗜中性粒细胞白血病继发骨髓纤维化的影响。
Ann Hematol. 2021 Oct;100(10):2639-2641. doi: 10.1007/s00277-020-04185-1. Epub 2020 Jul 16.
4
Durable remission with ruxolitinib in a chronic neutrophilic leukemia patient harboring a truncation and membrane proximal CSF3R compound mutation.鲁索替尼使一名患有截短型和膜近端CSF3R复合突变的慢性嗜中性粒细胞白血病患者实现持久缓解。
Ann Hematol. 2021 Feb;100(2):581-584. doi: 10.1007/s00277-020-04152-w. Epub 2020 Jun 23.
5
Changes in allele frequencies of and mutations and evidence of clonal evolution in a chronic neutrophilic leukemia patient treated with ruxolitinib.使用鲁索替尼治疗的慢性嗜中性粒细胞白血病患者中JAK2和CALR突变的等位基因频率变化及克隆进化证据
Haematologica. 2017 May;102(5):e207-e209. doi: 10.3324/haematol.2016.163089. Epub 2017 Feb 16.
6
Ruxolitinib, a potent JAK1/JAK2 inhibitor, induces temporary reductions in the allelic burden of concurrent mutations in chronic neutrophilic leukemia.芦可替尼是一种有效的JAK1/JAK2抑制剂，可使慢性嗜中性粒细胞白血病中并发突变的等位基因负担暂时降低。
Haematologica. 2017 Jun;102(6):e238-e240. doi: 10.3324/haematol.2017.163790. Epub 2017 Mar 16.
7
Insights on mechanisms of clonal evolution in chronic neutrophilic leukemia on ruxolitinib therapy.芦可替尼治疗慢性嗜中性粒细胞白血病的克隆进化机制研究
Leukemia. 2020 Jun;34(6):1684-1688. doi: 10.1038/s41375-019-0688-1. Epub 2019 Dec 16.
8
Chronic neutrophilic leukemia with concurrent CSF3R and SETBP1 mutations: single colony clonality studies, in vitro sensitivity to JAK inhibitors and lack of treatment response to ruxolitinib.伴有CSF3R和SETBP1基因突变的慢性嗜中性粒细胞白血病：单克隆集落克隆性研究、对JAK抑制剂的体外敏感性及对鲁索替尼治疗无反应
Leukemia. 2014 Jun;28(6):1363-5. doi: 10.1038/leu.2014.39. Epub 2014 Jan 21.
9
The CSF3R T618I mutation causes a lethal neutrophilic neoplasia in mice that is responsive to therapeutic JAK inhibition.CSF3R T618I 突变导致小鼠发生致命性中性粒细胞肿瘤，对治疗性 JAK 抑制有反应。
Blood. 2013 Nov 21;122(22):3628-31. doi: 10.1182/blood-2013-06-509976. Epub 2013 Sep 30.
10
Chronic neutrophilic leukemia, a rare case of leukocytosis.慢性嗜中性粒细胞白血病，一种罕见的白细胞增多症病例。
Leuk Res. 2020 Jul;94:106384. doi: 10.1016/j.leukres.2020.106384. Epub 2020 May 15.

引用本文的文献

1
Chronic Neutrophilic Leukemia: Advances in Diagnosis, Genetic Insights, and Management Strategies.慢性中性粒细胞白血病：诊断、遗传学见解及管理策略的进展
Cancers (Basel). 2025 Jan 12;17(2):227. doi: 10.3390/cancers17020227.
2
Research progress of additional pathogenic mutations in chronic neutrophilic leukemia.慢性中性粒细胞白血病中附加致病性突变的研究进展。
Ann Hematol. 2024 Aug;103(8):2591-2600. doi: 10.1007/s00277-023-05550-6. Epub 2023 Nov 22.